The DOI matches its Crossref record.
Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This antibody has been highly used in the field by many groups to track PKA-dependent phosphorlyation status of cTnI in cardiac muscle11–15.”
From Cytoplasmic nucleic acid-based XNAs directly enhance live cardiac cell function by a Ca2+ cycling-independent mechanism via the sarcomere (2019) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 46
- Maron, 1995, Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study, Circulation, 92, 785, 10.1161/01.CIR.92.4.785 · DOI · Paper page
- Go, 2013, Heart disease and stroke statistics—2014 update: a report from the American Heart Association, Circulation, 129, e28, 10.1161/01.cir.0000441139.02102.80 · DOI · Paper page
- Morita, 2008, Shared genetic causes of cardiac hypertrophy in children and adults, N Engl J Med, 358, 1899, 10.1056/NEJMoa075463 · DOI · Paper page
- Harris, 2011, In the thick of it: HCM-causing mutations in myosin binding proteins of the thick filament, Circ Res, 108, 751, 10.1161/CIRCRESAHA.110.231670 · DOI · Paper page
- Watkins, 1995, Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy, Nat Genet, 11, 434, 10.1038/ng1295-434 · DOI · Paper page
- Bonne, 1995, Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy, Nat Genet, 11, 438, 10.1038/ng1295-438 · DOI · Paper page
- Niimura, 1998, Mutations in the gene for cardiac myosin-binding protein c and late-onset familial hypertrophic cardiomyopathy, N Engl J Med, 338, 1248, 10.1056/NEJM199804303381802 · DOI · Paper page
- Moolman, 2000, A newly created splice donor site in exon 25 of the MyBP-C gene is responsible for inherited hypertrophic cardiomyopathy with incomplete disease penetrance, Circulation, 101, 1396, 10.1161/01.CIR.101.12.1396 · DOI
- Alcalai, 2008, Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics, J Cardiovasc Electrophysiol, 19, 104, 10.1111/j.1540-8167.2007.00965.x · DOI · Paper page
- Knöll, 2012, Myosin binding protein C: implications for signal-transduction, J Muscle Res Cell Motil, 33, 31, 10.1007/s10974-011-9281-6 · doi:10.1007/s10974-011-9281-6
- Marston, 2009, Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency, Circ Res, 105, 219, 10.1161/CIRCRESAHA.109.202440 · DOI · Paper page
- van Dijk, 2009, Cardiac myosin-binding protein c mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction, Circulation, 119, 1473, 10.1161/CIRCULATIONAHA.108.838672 · DOI · Paper page
- McConnell, 1999, Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice, J Clin Invest, 104, 1235, 10.1172/JCI7377 · DOI · Paper page
- Harris, 2002, Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice, Circ Res, 90, 594, 10.1161/01.RES.0000012222.70819.64 · DOI · Paper page
- Carrier, 2004, Asymmetric septal hypertrophy in heterozygous cMyBP-C null mice, Cardiovasc Res, 63, 293, 10.1016/j.cardiores.2004.04.009 · DOI
- Vignier, 2009, Nonsense-mediated mRNA decay and ubiquitin–proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice, Circ Res, 105, 239, 10.1161/CIRCRESAHA.109.201251 · DOI · Paper page
- Cheng, 2013, Impaired contractile function due to decreased cardiac myosin binding protein C content in the sarcomere, Am J Physiol Heart Circ Physiol, 305, H52, 10.1152/ajpheart.00929.2012 · DOI
- Barefield, 2014, Contractile dysfunction in a mouse model expressing a heterozygous MYBPC3 mutation associated with hypertrophic cardiomyopathy, Am J Physiol Heart Circ Physiol, 306, H807, 10.1152/ajpheart.00913.2013 · DOI
- Kuster, 2014, MYBPC3's alternate ending: consequences and therapeutic implications of a highly prevalent 25bp deletion mutation, Pflugers Arch, 466, 207, 10.1007/s00424-013-1417-7 · DOI
- Christodoulou, 2014, 5′RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy, J Clin Invest, 124, 1364, 10.1172/JCI70108 · DOI
- Dorn, 2014, Two strikes and you're out: gene–gene mutation interactions in HCM, Circ Res, 115, 208, 10.1161/CIRCRESAHA.114.304383 · DOI
- Blankenburg, 2014, Beta-myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations, Circ Res, 115, 227, 10.1161/CIRCRESAHA.115.303178 · DOI
- Najafi, 2014, Sexual dimorphic response to exercise in hypertrophic cardiomyopathy-associated MYBPC3-targeted knock-in mice, Pflugers Arch
- Berul, 2001, Ventricular arrhythmia vulnerability in cardiomyopathic mice with homozygous mutant myosin-binding protein C gene, Circulation, 104, 2734, 10.1161/hc4701.099582 · doi:10.1161/hc4701.099582
- McConnell, 2001, Comparison of two murine models of familial hypertrophic cardiomyopathy, Circ Res, 88, 383, 10.1161/01.RES.88.4.383 · DOI
- Sadayappan, 2009, Cardiac myosin binding protein-C phosphorylation in a {beta}-myosin heavy chain background, Circulation, 119, 1253, 10.1161/CIRCULATIONAHA.108.798983 · DOI
- Verma, 2012, Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-kappaB, Circulation, 126, 418, 10.1161/CIRCULATIONAHA.112.112185 · DOI · Paper page
- Pfaffl, 2001, A new mathematical model for relative quantification in real-time RT-PCR, Nucleic Acids Res, 29, 2002, 10.1093/nar/29.9.e45 · DOI · Paper page
- Christodoulou, 2011, Construction of normalized RNA-seq libraries for next-generation sequencing using the crab duplex-specific nuclease, Curr Protoc Mol Biol, 10.1002/0471142727.mb0412s94 · DOI
- Sadayappan, 2005, Cardiac myosin binding protein-C phosphorylation and cardiac function, Circ Res, 97, 1156, 10.1161/01.RES.0000190605.79013.4d · DOI · Paper page
- Barefield, 2010, Phosphorylation and function of cardiac myosin binding protein-C in health and disease, J Mol Cell Cardiol, 48, 866, 10.1016/j.yjmcc.2009.11.014 · DOI · Paper page
- Sadayappan, 2006, Cardiac myosin binding protein-C phosphorylation is cardioprotective, Proc Natl Acad Sci U S A, 103, 16918, 10.1073/pnas.0607069103 · DOI · Paper page
- Sadayappan, 2011, A critical function for Ser-282 in cardiac myosin binding protein-C phosphorylation and cardiac function, Circ Res, 109, 141, 10.1161/CIRCRESAHA.111.242560 · DOI
- Copeland, 2010, Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle, J Mol Cell Cardiol, 49, 1003, 10.1016/j.yjmcc.2010.09.007 · DOI
- Chandra, 1997, Effects of protein kinase A phosphorylation on signaling between cardiac troponin I and the N-terminal domain of cardiac troponin C, Biochemistry, 36, 13305, 10.1021/bi9710129 · DOI
- Frazier, 2011, Molecular mechanisms of sarcomere dysfunction in dilated and hypertrophic cardiomyopathy, Prog Pediatr Cardiol, 31, 29, 10.1016/j.ppedcard.2010.11.006 · DOI
- Tong, 2008, Acceleration of crossbridge kinetics by protein kinase A phosphorylation of cardiac myosin binding protein C modulates cardiac function, Circ Res, 103, 974, 10.1161/CIRCRESAHA.108.177683 · DOI · Paper page
- Chen, 2012, Dissociation of structural and functional phenotypes in cardiac myosin-binding protein C conditional knockout mice, Circulation, 126, 1194, 10.1161/CIRCULATIONAHA.111.089219 · DOI
- Fraysse, 2012, Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice, J Mol Cell Cardiol, 52, 1299, 10.1016/j.yjmcc.2012.03.009 · DOI
- Mearini, 2008, The ubiquitin–proteasome system in cardiac dysfunction, Biochim Biophys, 1782, 749, 10.1016/j.bbadis.2008.06.009 · DOI
- Sorajja, 2000, The molecular genetics of hypertrophic cardiomyopathy: prognostic implications, Europace, 2, 4, 10.1053/eupc.1999.0067 · DOI
- Witayavanitkul, 2014, Myocardial infarction-induced N-terminal fragment of cardiac myosin-binding protein C (cMyBP-C) impairs myofilament function in human myocardium, J Biol Chem, 289, 8818, 10.1074/jbc.M113.541128 · DOI
- Jeong, 2013, Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament properties, J Mol Cell Cardiol, 56, 44, 10.1016/j.yjmcc.2012.12.003 · DOI
- Patel, 2013, Novel control of cardiac myofilament response to calcium by S-glutathionylation at specific sites of myosin binding protein C, Front Physiol, 4, 336, 10.3389/fphys.2013.00336 · doi:10.3389/fphys.2013.00336
- Dhandapany, 2009, A common MYBPC3 (cardiac myosin binding protein C) variant associated with cardiomyopathies in South Asia, Nat Genet, 41, 187, 10.1038/ng.309 · DOI · Paper page
- Fatkin, 2014, Genetics and disease of ventricular muscle, Cold Spring Harb Perspect Med, 4, a021063, 10.1101/cshperspect.a021063 · DOI
Cited by
Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy
Marian, A. J., & Braunwald, E. (2017) · Circulation Research · doi:10.1161/circresaha.117.311059 · Cited by 1,403
Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy
Burke, M. A., Cook, S. A., Seidman, J. G., & Seidman, C. E. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.08.079 · Cited by 325
Self-citationThompson, B. R., Soller, K. J., Vetter, A., Yang, J., Veglia, G., Bowser, M. T., & Metzger, J. M. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.02.016 · Cited by 2
Metadata
- Authors
- Barefield, D., Kumar, M., Gorham, J., Seidman, J. G., Seidman, C. E., de Tombe, P. P., & Sadayappan, S.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 79
- Pages
- 234-243
- ISSN
- 0022-2828
- Cited by
- 72
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- National Heart, Lung, and Blood Institute (R01HL-105826, K02HL-114749, HL-101297, HL-75494, P01HL62426)
- American Heart Association (11PRE7240022, 14GRNT20490025)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice. https://app.cochat.ai/papers/10.1016/j.yjmcc.2014.11.018
- The paper
- Barefield, D., Kumar, M., Gorham, J., Seidman, J. G., Seidman, C. E., de Tombe, P. P., & Sadayappan, S. (2015). Haploinsufficiency of MYBPC3 exacerbates the development of hypertrophic cardiomyopathy in heterozygous mice. Journal of Molecular and Cellular Cardiology. https://doi.org/10.1016/j.yjmcc.2014.11.018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.